Rodney Young
2022 - RAPT Therapeutics
In 2022, Rodney Young earned a total compensation of $1.5M as Chief Financial Officer at RAPT Therapeutics, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $956,415 |
| Salary | $435,000 |
| Total | $1,541,415 |
Young received $956.4K in option awards, accounting for 62% of the total pay in 2022.
Young also received $150K in non-equity incentive plan and $435K in salary.
Rankings
In 2022, Rodney Young's compensation ranked 2,170th out of 5,760 executives tracked by ExecPay. In other words, Young earned more than 62.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,170 out of 5,760 | 62nd |
Division Manufacturing | 1,168 out of 3,136 | 63rd |
Major group Chemicals And Allied Products | 503 out of 1,422 | 65th |
Industry group Drugs | 463 out of 1,323 | 65th |
Industry Pharmaceutical Preparations | 337 out of 969 | 65th |
Source: SEC filing on April 7, 2023.
Young's colleagues
We found two more compensation records of executives who worked with Rodney Young at RAPT Therapeutics in 2022.